XM does not provide services to residents of the United States of America.

Patients, medics flee south Gaza hospital after evacuation orders, WHO says



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-Patients, medics flee south Gaza hospital after evacuation orders, WHO says</title></head><body>

Adds details, comment from ICRC in paragraphs 5,6, Israeli defence official comment in 4,5

GENEVA, July 2 (Reuters) -Gaza's European Hospital in Khan Younis is virtually empty with staff and patients fleeing the facility after the Israeli army ordered residents in the surrounding areas to evacuate, a World Health Official spokesperson said on Tuesday.

Thousands of Palestinians, many of them already displaced multiple times in the more than eight-month conflict, have fled parts of southern Gaza since Monday amid Israeli bombardments.

"The hospital staff and the patients decided to already evacuate themselves," said Rik Peeperkorn, WHO Representative for the occupied Palestinian territories, adding that just three patients remained. "We plea the European Gaza hospital will be spared, will be non-damaged," he told the U.N. press briefing, speaking by video link from Jerusalem.

An Israeli defence official said that although evacuation orders had been issued for the area in which the hospital is located, staff and patients were told they could stay.

We didn't give them any order to evacuate. So patients and the medical teams can stay over there. It's safe for them," said Colonel Elad Goren of COGAT, the Israeli Defence Ministry agency that coordinates with the Palestinians in a phone briefing with reporters.

The International Committee of the Red Cross, which had a medical team in the hospital, including surgeons, is moving its team and patients to a field hospital in Rafah-Mawasi, it said in a statement.

"As evacuations continue to affect so many people, it is critical that safe transport for those who are disabled, the elderly, and the sick is provided," it said.



Reporting by Emma Farge in Geneva and Emily Rose in Jerusalem: Editing by Madeline Chambers and Sharon Singleton

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.